cholestyramine powder for suspension
NDC 67877-298, cholestyramine powder for suspension, powder, for suspension, from Ascend Laboratories, LLC.
- Product NDC
- 67877-298
- Status
- Listed
- Labeler
- Ascend Laboratories, LLC
- Dosage form
- POWDER, FOR SUSPENSION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA211856
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/67877-298 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CHOLESTYRAMINE4 g/8.78g
Pharmacologic classes
Bile Acid Sequestrant [EPC]; Bile-acid Binding Activity [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 67877-298-37 | 67877029837 | 368.76 g in 1 JAR (67877-298-37) |
| 67877-298-60 | 67877029860 | 60 POUCH in 1 CARTON (67877-298-60) / 8.78 g in 1 POUCH (67877-298-09) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/430ac07e-8524-4dec-a599-b7ebc56d9563NADAC price for package 67877029837
GET /v1/drugs/nadac/67877029837NADAC price for package 67877029860
GET /v1/drugs/nadac/67877029860
Use it
Look up 67877-298 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/67877-298 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 67877-298. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.